Happy to share our new paper in @CKJsocial
In 1,324 adults from RENIS, with repeated iohexol-measured GFR over 10 years, higher habitual protein intake was not associated with faster kidney function decline.
https://t.co/QZmvqvB0pE
#WorldKidneyDay
🌸Spring is really the season to celebrate nephrology
💬 2017- I started nephrology residency; the 2012 CKD guidelines were still in place. The only 1A class recommendation was to consider people with CKD as high CV risk 💔
👇My few takeouts #nephtwitter
Ikke hverdagskost med publikasjon i @nejm for @UiTNorgesarktis! Professor @ToralfMelsom og resten i the European Kidney Function Consortium har publisert en ny GFR-ligning basert på cystatin C som beregner nyrefunksjonen mer presis en tidligere
https://t.co/0hxshtbkyh
New article out! Check out this article by @FridtjofRinde about D-dimer as a stand-alone test to rule out DVT. D-dimer alone reduced the proportion of required ultrasounds by almost 10% and may be safe for excluding proximal DVT. Link to the article: https://t.co/Vlal9KjpM7
Greit å informere om at «eksperten» som fikk spre frykt og dommedagsprofetier i 45 (!) minutter på @NRKno har publisert 3 artikler de siste 8 årene - om helt andre ting enn det hun pratet om i kveld. #nrkdebatten#debatten@fredriksolvang
@JonLaake Hei! Hva er dine tanker om bruk av steroider hos pasienter med sepsis? Er ikke vant med at dette brukes i stor grad, men det ser hvertfall ut som dette er noe evidensbasert. Kan det brukes i enkelte subgrupper, som de med refraktært sjokk? https://t.co/HFtSr83aOB
@kidney_boy I'm working as an intern at a cardiology department. Recently, we started with hydrochlortiazide in a patent with cognestive heart failure and eGFR 25. But are thiazide diuretics effective in patients with reduced renal function? #askrenal
@MaryCushmanMD Impressive work! Guidelines like this are educational and inspiring for young clinicians/researchers as myself! I'm wondering if you have any opinions regarding extended-duration in selected high-risk patients (eg stroke patients)? Would the MARINER trial changed any conclusions?
@mmonrealriete Is this nice table from a published paper? The numbers look very interesting! What do you think about extended vs standard duration thromboprophylaxis in patients with ischemic stroke and other high risk conditions?
@mmonrealriete In curiosity, what is the true proportion of hospital-related Vte events? I have read numbers ranging from 40 to 60%. Enjoy to read your tweets about VTE! 👏
Ludvig Balteskard Rinde (@LRinde) skal etter planen disputere 12. desember - knapt seks måneder etter endt medisinstudie! Vi har intervjuet han om hvordan det har skjedd og hvilke planer han har videre - les om det her: https://t.co/vCy1rYOEsu